Metabolic syndrome rose over two years; cannabis use was associated with lower…

Risk factors for metabolic syndrome in first episode psychosis.

Schizophrenia research • • Review • Related
🤖

AI Summary

This observational, longitudinal study followed 456 people with first-episode psychosis in Spain for two years, assessing metabolic syndrome every six months. The proportion meeting the study’s criteria increased from 7.4% at baseline to 11% at 12 months and 17.1% at 24 months.

Older age, being male, heavy tobacco use, negative psychiatric symptoms, and childhood sexual abuse were associated with higher odds of metabolic syndrome; better functioning and higher socioeconomic status were associated with lower odds. Cannabis use was also associated with reduced odds, but this observational finding does not show that cannabis prevents metabolic syndrome or causes the difference. The abstract does not report effect sizes, and the study cannot establish causation; this is an abstract-based summary, not a review of the full text.

💡 Key Findings

1
Metabolic syndrome prevalence increased from 7.4% at baseline to 17.1% at 24 months among people with first-episode psychosis.
High
80%
2
Cannabis use was associated with reduced odds of metabolic syndrome; the observational study cannot determine whether cannabis caused this association.
Good
75%
3
Older age, male sex, heavy tobacco consumption, negative psychiatric symptoms, and childhood sexual abuse were associated with higher odds; better functioning and higher socioeconomic status with lower odds.
Good
75%

📄 Original Abstract

OBJECTIVE: Metabolic syndrome (MetS) is a multifaceted disorder characterized by a constellation of interrelated factors. It is associated with reduced life expectancy and diminished quality of life in individuals with first-episode psychosis (FEP). This observational, longitudinal study assessed the progression of MetS in individuals with FEP over a two-year follow-up period and identified variables that predict the onset of Mets. METHODS: The study was conducted through the Programa de Primeros Episodios de Psicosis de Navarra (PEPsNa) program in Spain, recruiting 456 FEP patients (66% male; mean age = 30.76) between 2019 and 2024, with data collected every six months. MetS was assessed using the ATP-III criteria. RESULTS: The baseline prevalence of MetS was 7.4%, increasing to 11% at 12 months and 17.1% at 24 months. Several variables were positively associated with MetS, including, older age, male, heavy tobacco consumption (>20 cigarettes daily), negative psychiatric symptoms, and history of sexual abuse in childhood. In contrast, better overall functioning and a high socioeconomic status, were associated with lower odds of MetS. Cannabis use was unexpectedly associated with reduced odds of MetS. CONCLUSION: This research represents a comprehensive analysis of premorbid, psychosocial, and demographic variables as factors associated with MetS development in patients with FEP, providing valuable insights into early intervention opportunities.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.